Esperion Therapeutics Inc (NASDAQ:ESPR)

5.24
Delayed Data
As of Dec 03
 -3.73 / -41.58%
Today’s Change
4.96
Today|||52-Week Range
39.49
-79.85%
Year-to-Date

Today’s Trading

Previous close8.97
Today’s open6.08
Day’s range4.97 - 6.10
Volume1,532,830
Average volume (3 months)1,410,642
Market cap$261.4M
Data as of 4:53pm ET, 12/03/2021

Growth & Valuation

Earnings growth (last year)-45.68%
Earnings growth (this year)+73.80%
Earnings growth (next 5 years)-66.56%
Revenue growth (last year)+53.37%
P/E ratioNM
Price/Sales3.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCYXSCYNEXIS Inc-0.30-4.50%
VIRXViracta Therapeutics...-0.18-4.21%
ORTXOrchard Therapeutics...-0.07-5.47%
MNOVMediciNova Inc-0.04-1.27%
Data as of 3:59pm ET, 12/03/2021

Financials

Next reporting dateFebruary 22, 2022
EPS forecast (this quarter)-$2.70
Annual revenue (last year)$227.5M
Annual profit (last year)-$143.6M
Net profit margin-63.09%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Ann Arbor, Michigan

Forecasts